Nephros (NEPH) Enterprise Value (2010 - 2026)

Nephros has reported Enterprise Value for 17 years, with the latest figure at $34.1 million in Q2 2026.

• On a quarterly basis, Enterprise Value fell 10.99% year-over-year to $34.1 million in Q2 2026; TTM through Jun 2026 was $34.1 million, a 10.99% decrease from a year earlier, with the FY2025 full-year figure at $46.5 million, up 296.43% from the prior year.
• Enterprise Value was $34.1 million for Q2 2026 at Nephros, up from $28.3 million in the prior quarter.
• The five-year high for Enterprise Value was $46.5 million in Q4 2025, with the low at $7.4 million in Q1 2023.
• Average Enterprise Value over 5 years is $23.0 million, with a median of $17.4 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Enterprise Value slumped 89.8% in 2022, then jumped 296.43% in 2025.
• Over 5 years, Enterprise Value stood at $11.6 million in 2022, then surged by 178.1% to $32.2 million in 2023, then slumped by 63.51% to $11.7 million in 2024, then surged by 296.43% to $46.5 million in 2025, then declined by 26.79% to $34.1 million in 2026.
• The last three Enterprise Value figures came in at $34.1 million (Q2 2026), $28.3 million (Q1 2026), and $46.5 million (Q4 2025), per Business Quant data.